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CASE REPORT
Progressive multifocal leukoencephalopathy (PML)
is a fatal, progressive disease due to infection by
the Jamestown Canyon virus (JCV). It occurs in
patients with defects in cell-mediated immunity,
including those with acquired immunodeficiency
syndrome (AIDS) and other immunocompro-
mised diseases. This disease is an important cause
of morbidity and mortality in AIDS patients.
JCV affects oligodendrocytes almost exclusively,
causing demyelination. Symptoms include pro-
gressive focal and diffuse deficits (visual, motor,
cognitive deficits and memory loss, personality
change), leading to death within a few months
after diagnosis.1
We report a 34-year-old HIV positive man who
presented with generalized tonic clonic seizure
and left side weakness for 2 months with typical
magnetic resonance imaging (MRI) findings and
a rapidly fatal clinical course. JCV-associated PML
was diagnosed at autopsy.
Case Report
A 34-year-old man was robust before when he de-
veloped a general tonic clonic seizure, an upward
gaze that lasted for 5 minutes on July 7, 2004. 
He underwent brain computed tomography at 
a local hospital, which showed a hypodense le-
sion suspected to be a brain tumor. On July 12,
brain MRI showed multiple lesions in flare sig-
nal. No abnormal vascular lesion was detected
on magnetic resonance angiography taken on July
17 in Chung Gung Memorial Hospital (CGMH).
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Left side weakness and left facial palsy developed
during the 1st week of August, but he did not seek
treatment. On August 7, another episode of general
tonic clonic seizure occurred and lasted for 2 min-
utes. On arrival at CGMH emergency room, he was
clear but left side muscle power decreased. He
was put on oral phenytoin 300 mg at bed time and
was discharged. Another episode of seizure attack
with general tonic clonic seizure lasting for 1–2
minutes occurred on August 21. Hemiplegia devel-
oped and he visited the neurosurgery department
of CGMH on August 23. Western blot test for HIV-1
was positive. He was transferred to the neuro-
surgery department in Tzu-Chi Hospital for further
evaluation and management on September 1.
After admission, carbamazepine 200 mg one
tablet BID and phenytoin 100 mg one tablet TID
were given to control the seizure and he was trans-
ferred to the infectious ward the next day. MRI
showed a large area of hyperintense signal on T2-
weighted image and T2 fluid attenuated inversion
recovery signal change showed low density in the
right fronto-tempo-parietal, left frontal, and left
parietal lobes (Figure 1A). Involvement of right
basal ganglia, right thalamus, right side midbrain,
and pons was also noted. Contrast injection study
showed no apparent abnormal enhancement
(Figure 1B). Opportunistic infection including her-
pes simplex IgM, cytomegalovirus IgM, toxoplasma
antibody, varicella IgM and IgG, Grocott’s methena-
mine silver nitrate stain of sputum for Pneumocystis
jiroveci, Treponema pallidum hemagglutination assay,
Venereal Disease Research Laboratory (VDRL),
cryptococcus antigen were checked and all were
negative. Antiretrovial therapy including Kaletra
(lopinavir 133.3 mg and ritonavir 33.3 mg/cap)
three tablets two times a day and Combivir
(lamivudine 150 mg and zidovudine 300 mg) one
tablet two times a day were given. His CD4 cell
count was as low as 40 μg/dL and prophylactic
antibiotics including Baktar (sulfamethoxazole
400 mg and trimethoprim 80 mg/5 mL/1 amp)
15 mL iv every 8 hours, fluconazole (200 mg) drip
daily, clarithromycin (500 mg) one tablet BID, 
rifabutin (150 mg) one cap two times a day, lev-
ofloxacin 500 mg one tablet daily were prescribed.
Penicillin G 3MU intravenous every 6 hours was
given to treat syphilis after plasma VDRL test was
positive. Gancyclovir 250 mg intravenous every
12 hours was given due to suspected cytomega-
lovirus retinitis but discontinued after ophthal-
mologist consultation excluded this diagnosis.
Another episode of generalized tonic clonic seizure
occurred on September 10. Mannitol 20%, 50cc
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Figure 1. (A) Axial T2-weighted image shows bilateral, asymmetric, patchy hyperintensities in bilateral subcortical white
matter with a slightly layered lesion in the right frontoparietal lobe. (B) Postcontrast, T1-weighted image shows no apparent
enhancement.
dripped every 8 hours was given to decrease in-
tracranial pressure. He became stuporous, with
extention response to pain stimulation and aniso-
coric pupils with eyes deviated to the left. Baclofen
5 mg/tab one tablet three times a day was given
for muscle rigidity. Depakine (Valproate Na
200 mg) one tablet three times a day and clon-
azepam (0.5 mg) one tablet every night were used
for anticonvulsion. Combivir (lamivudine 150 mg
and zidovudine 300 mg) was shifted to stavudine
(zerit, D4T) 40 mg every 12 hours and didano-
sine (videx, ddI) 400 mg daily due to leukopenia
developing, probably due to zidovudine. Fever and
dyspnea developed on September 23 and he died
on October 9.
Autopsy was performed after 24 hours. The
main lesions were in the brain. Serial brain sec-
tions showed multiple softened areas involving
the subcortical white matter of the right frontal,
right temporal, bilateral parietal, bilateral occipital,
right basal gangliar and cerebellar regions and 
in the brain stem (Figure 2A). Histopathology
showed multifocal demyelination (Figure 2B) with
foamy cell aggregation accompanied by bizarre
astrocyte proliferation and characteristic baso-
philic intranucleus inclusion body formation in
the oligodendrocytes (Figure 2C). Immunohisto-
chemical staining failed to show JCV protein in
the oligodendrocytes. JCV in situ hybridization
performed as previously described2 demonstrated
JCV genome in the nucleus of oligodendrocytes
(Figure 2D).
Discussion
PML is a demyelinating disorder of the human
brain caused by JCV. Up to 80% of humans express
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Figure 2. (A) Coronal section shows multiple foci of subcortical leukoencephalomalacia. (B) Histopathology shows a large
area of demyelination with foamy macrophage aggregation (hematoxylin & eosin [H & E], 40×). (C) Histopathology
shows large oligodendrocytes with basophilic inclusion body formation (arrows) (H & E, 400×). (D) In situ hybridization
shows Jamestown Canyon virus genomes (in situ hybridization, 400×).
serum antibodies to JCV,3,4 yet only a very small
percentage develop PML—predominantly those
with immunosuppressive conditions. The AIDS
pandemic has led to a much higher incidence of
PML in the last 20 years; about 5% of all patients
with AIDS develop PML.5
PML is a disorder of the brain induced by the
lytic infection of myelin-producing oligodendro-
cytes by JCV. Initial demyelination occurs as mul-
tiple foci sparsely distributed in the subcortical
white matter. With disease progression, each focus
grows as virus spreads from cell to cell. Ultimately,
microscopic areas of necrosis become macroscopic
plaque lesions up to centimeters in diameter. The
three main pathologic features of PML are de-
myelinated lesions accompanied by abnormally
large oligodendroglial nuclei with basophilic in-
clusion bodies and bizarre enlarged astrocytes.
Macrophages are often present in PML lesions;
their likely role is the removal of myelin break-
down products or damaged oligodendrocytes,6,7
as in this case.
Immunohistochemical staining and in situ hy-
bridization have been applied to detect JCV in PML
lesions. In this case, in situ hybridization showed
JCV genome diffusely in the oligodendrocytes,
but immunohistochemical staining was negative.
In situ hybridization has proven to be more sensi-
tive than immunohistochemistry in detecting JCV
capsid proteins,5,8 as in this case. Virus is less fre-
quently detected in astrocytes than oligodendro-
cytes, and neuronal loss is rare, with sparing of
demyelinated axons.9
MRI of PML includes high-signal lesions in
multifocal white matter in T2-weighted image
and no enhancement in postcontrast image,10–12
all of which were found in this case.
The multifocal nature of PML results in a vari-
ety of neurologic symptoms including visual 
impairment or blindness, motor dysfunction or
weakness, and dementia and other cognitive ab-
normalities, such as personality change, memory
loss, or emotional lability.13 These symptoms can
vary in order of presentation and severity, but most
patients develop all three. Less common manifes-
tations include vertigo, headache, seizures, sensory
deficits, and parkinsonism.13 In this case, atypical
presentation with generalized tonic clonic seizure
occurred. Usually, disease progression is rather
rapid, with death within a year after diagnosis;
some patients survive for several years.14
Prior to highly active antiretroviral therapy
(HAART), there was no effective therapy for PML.
Since the advent of HAART, prognosis for PML has
much improved; however, a significant number of
patients are unresponsive to antiretroviral therapy
and some worsen because of the development of
immune reconstitution disease.15 A better under-
standing of the biology of JCV and its interactions
with host immunity are leading to new anti-JCV-
specific agents that await evaluation in random-
ized controlled trials. Improved diagnostic tools
and the possibility of immunotherapy and gene
therapy are further advancing the prospects of
improved management of this condition.16
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